FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

823027003: Lasmiditan (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2020. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3866786017 Lasmiditan (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3866787014 Lasmiditan en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lasmiditan (substance) Is a Benzamide (substance) false Inferred relationship Some
Lasmiditan (substance) Is a Substance with serotonin receptor agonist mechanism of action (substance) true Inferred relationship Some
Lasmiditan (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Serotonin receptor agonist false Inferred relationship Some
Lasmiditan (substance) Is a Substance with benzamide structure true Inferred relationship Some
Lasmiditan (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Serotonin 5-hydroxytryptamine-1 receptor agonist (disposition) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Lasmiditan-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lasmiditan (substance) Inferred relationship Some 1
Product containing only lasmiditan (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lasmiditan (substance) Inferred relationship Some 1
Product containing lasmiditan in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lasmiditan (substance) Inferred relationship Some 1
Lasmiditan only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lasmiditan (substance) Inferred relationship Some 1
Lasmiditan 50 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Lasmiditan (substance) Inferred relationship Some 1
Lasmiditan 50 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Lasmiditan (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start